Approximately 2% of such JAK2-negative PV patients harbour a mutation in the gene SH2B3 (also known as LNK), which encodes an inhibitor of cytokine-dependent cell growth in hematopoietic cells. Here, SH2B3 is linked to acquired polycythemia vera.